메뉴 건너뛰기




Volumn 64, Issue 18, 2014, Pages 1883-1890

Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device

Author keywords

atrial fibrillation; left ventricular assist device; thromboembolism

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

EID: 84908370862     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.07.989     Document Type: Article
Times cited : (75)

References (14)
  • 1
    • 79955933219 scopus 로고    scopus 로고
    • 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines
    • V. Fuster, L.E. Ryden, and D.S. Cannom 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines J Am Coll Cardiol 57 2011 e101 e198
    • (2011) J Am Coll Cardiol , vol.57 , pp. e101-e198
    • Fuster, V.1    Ryden, L.E.2    Cannom, D.S.3
  • 2
    • 84860834237 scopus 로고    scopus 로고
    • Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients
    • A. Brenyo, M. Rao, and S. Koneru Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients J Cardiovasc Electrophysiol 23 2012 515 520
    • (2012) J Cardiovasc Electrophysiol , vol.23 , pp. 515-520
    • Brenyo, A.1    Rao, M.2    Koneru, S.3
  • 3
    • 0031686381 scopus 로고    scopus 로고
    • Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction
    • D.L. Dries, D.V. Exner, and B.J. Gersh Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction J Am Coll Cardiol 32 1998 695 703
    • (1998) J Am Coll Cardiol , vol.32 , pp. 695-703
    • Dries, D.L.1    Exner, D.V.2    Gersh, B.J.3
  • 4
    • 84889248873 scopus 로고    scopus 로고
    • Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation
    • J.M. Stulak, S. Deo, and J. Schirger Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation Ann Thorac Surg 96 2013 2161 2167
    • (2013) Ann Thorac Surg , vol.96 , pp. 2161-2167
    • Stulak, J.M.1    Deo, S.2    Schirger, J.3
  • 5
    • 83055170874 scopus 로고    scopus 로고
    • Arrhythmias in patients with ventricular assist devices
    • A. Boyle Arrhythmias in patients with ventricular assist devices Curr Opin Cardiol 27 2012 13 18
    • (2012) Curr Opin Cardiol , vol.27 , pp. 13-18
    • Boyle, A.1
  • 6
    • 70349191771 scopus 로고    scopus 로고
    • Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation
    • E.A. Genovese, M.A. Dew, and J.J. Teuteberg Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation Ann Thorac Surg 88 2009 1162 1170
    • (2009) Ann Thorac Surg , vol.88 , pp. 1162-1170
    • Genovese, E.A.1    Dew, M.A.2    Teuteberg, J.J.3
  • 7
    • 33646254610 scopus 로고    scopus 로고
    • Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program
    • L.G. Olsson, K. Swedberg, and A. Ducharme Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program J Am Coll Cardiol 47 2006 1997 2004
    • (2006) J Am Coll Cardiol , vol.47 , pp. 1997-2004
    • Olsson, L.G.1    Swedberg, K.2    Ducharme, A.3
  • 8
    • 0027229344 scopus 로고
    • The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT studies. The V-HeFT VA Cooperative Studies Group
    • P.E. Carson, G.R. Johnson, and W.B. Dunkman The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT studies. The V-HeFT VA Cooperative Studies Group Circulation 87 1993 VI102 VI110
    • (1993) Circulation , vol.87 , pp. VI102-VI110
    • Carson, P.E.1    Johnson, G.R.2    Dunkman, W.B.3
  • 9
    • 33751528329 scopus 로고    scopus 로고
    • Does rhythm matter? The prognostic importance of atrial fibrillation in heart failure
    • C.A. Wasywich, G.A. Whalley, G.D. Gamble, S.P. Wright, and R.N. Doughty Does rhythm matter? The prognostic importance of atrial fibrillation in heart failure Heart Lung Circ 15 2006 353 357
    • (2006) Heart Lung Circ , vol.15 , pp. 353-357
    • Wasywich, C.A.1    Whalley, G.A.2    Gamble, G.D.3    Wright, S.P.4    Doughty, R.N.5
  • 10
    • 78049460418 scopus 로고    scopus 로고
    • First experience of percutaneous radio-frequency ablation for atrial flutter and atrial fibrillation in a patient with HeartMate II left ventricular assist device
    • P. Maury, C. Delmas, and C. Trouillet First experience of percutaneous radio-frequency ablation for atrial flutter and atrial fibrillation in a patient with HeartMate II left ventricular assist device J Interv Card Electrophysiol 29 2010 63 67
    • (2010) J Interv Card Electrophysiol , vol.29 , pp. 63-67
    • Maury, P.1    Delmas, C.2    Trouillet, C.3
  • 11
    • 84855585557 scopus 로고    scopus 로고
    • Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices
    • J. Suarez, C.B. Patel, and G.M. Felker Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices Circ Heart Fail 4 2011 779 784
    • (2011) Circ Heart Fail , vol.4 , pp. 779-784
    • Suarez, J.1    Patel, C.B.2    Felker, G.M.3
  • 12
    • 67650093608 scopus 로고    scopus 로고
    • Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device
    • F.D. Pagani, L.W. Miller, and S.D. Russell Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device J Am Coll Cardiol 54 2009 312 321
    • (2009) J Am Coll Cardiol , vol.54 , pp. 312-321
    • Pagani, F.D.1    Miller, L.W.2    Russell, S.D.3
  • 13
    • 68949202239 scopus 로고    scopus 로고
    • Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: Analysis of outpatient anti-coagulation
    • A.J. Boyle, S.D. Russell, and J.J. Teuteberg Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation J Heart Lung Transplant 28 2009 881 887
    • (2009) J Heart Lung Transplant , vol.28 , pp. 881-887
    • Boyle, A.J.1    Russell, S.D.2    Teuteberg, J.J.3
  • 14
    • 84892151754 scopus 로고    scopus 로고
    • Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device
    • J.M. Stulak, D. Lee, and J.W. Haft Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device J Heart Lung Transplant 33 2014 60 64
    • (2014) J Heart Lung Transplant , vol.33 , pp. 60-64
    • Stulak, J.M.1    Lee, D.2    Haft, J.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.